A Long Term Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia Converted From Erythropoieses Stimulating Agent (ESA) Treatment
Clinical trial NCT02779764 · COMPLETED
Trial details
- NCT number
- NCT02779764
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-16
- Primary completion
- 2017-05-16
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.